Skip to content
Horizon3BioTech
  • Investor Resources
  • Team
  • Resources
    • Podcasts
  • Portfolio
  • FAQ
  • Contact
  • Subscribe
  • Investor Resources
  • Team
  • Resources
    • Podcasts
  • Portfolio
  • FAQ
  • Contact
  • Subscribe

Blog

BioBullets: The Aduhelm FDA approval controversy

https://www.buzzsprout.com/1763087/9022172-biobullets-the-aduhelm-fda-approval-controversy.mp3

This podcast accompanies Horizon 3 Biotech's BioBullets email for the 13th August 2021

Read more articles

Previous PostEpisode 8 – Investing in Biotech
Next PostEpisode 9 – Investing in Biotech

Recent Posts

  • Episode 13 – Investing in Biotech
  • Episode 12 – Investing in Biotech
  • Investing in Biotech
  • BioBullets: The Great Dispersion
  • Episode 11 – Investing in Biotech
  • Episode 10 – Investing in Biotech
  • Episode 9 – Investing in Biotech
  • BioBullets: The Aduhelm FDA approval controversy
  • Episode 8 – Investing in Biotech
  • Episode 7 – Investing in Biotech
  • Introduction to Horizon 3
  • Topical investment strategies in biotech
  • Investor Resources
  • Team
  • Resources
  • Portfolio
  • FAQ
  • Contact
  • Subscribe
  • Disclaimer
Copyright 2020 - Horizon3Biotech